CNBC's "Fast Money" More Tariff Concerns Send Markets Lowers, and Is a Breakout Coming for Biotech? 7/7/25
9 snips
Jul 7, 2025 Lorraine Hutchinson, a Bank of America analyst, sheds light on the repercussions of President Trump's 25% tariffs on imports from Japan and South Korea, especially for retailers sourcing from Vietnam. The conversation dives into how these tariffs are reshaping U.S. market dynamics and investor sentiment. Additionally, Hutchinson discusses the ongoing biotech surge since April, exploring whether this trend can maintain momentum amidst such market volatility. Tune in for compelling insights on trade relations and biotech stock performance!
AI Snips
Chapters
Transcript
Episode notes
Tariff Headline Risk Hits Market
- The market pullback is mainly due to tariff headline risk and uncertainty about trade policy execution.
- Investors are cautiously digesting the implications of new 25% tariffs against major partners like Japan and South Korea.
Market Regards Tariffs as Rhetoric
- Despite tariff announcements, markets view these as rhetoric likely to be postponed or scaled back.
- Investors generally believe definitive tariff actions impacting the economy are still avoidable.
Tariffs Triggered Past Market Swings
- The market previously dropped sharply on tariff fears but rebounded quickly once policy softened.
- This history suggests tariff risks might be managed but growth concerns remain due to tariffs and Fed policy.